Lupus Foundation of America1d
IGM Biosciences Halts Development of Two Investigational Treatments for People with Autoimmune and Inflammatory Diseases
IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including ...
Lupus Foundation of America2d
New Study Highlights Evidence Gaps and Under-Representation in Lupus Nephritis Clinical Trials
In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess ...
Lupus Foundation of America3d
People Living with Systemic Lupus Erythematosus Demonstrate Clinically Meaningful Improvement with Cenerimod
In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of ...
Lupus Foundation of America4d
REGINA-006
The REGINA SLE clinical trial is testing an investigational study drug to see if it may safely and effectively reduce symptoms of moderate to severe systemic lupus erythematosus in adults.